Characterization, optimization, and in vitro evaluation of cholesterol-free liposomes

[1]  Xin Hu,et al.  Lactobacillus buchneri S-layer protein-coated liposomes loaded with β-cyclodextrin-carvacrol inclusion complexes for the enhancement of antibacterial effect. , 2022, Food research international.

[2]  S. Bolboacă,et al.  Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity , 2022, Antioxidants.

[3]  W. M. van der Flier,et al.  Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 , 2021, Alzheimer's Research & Therapy.

[4]  C. Banchio,et al.  Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress , 2021, Scientific Reports.

[5]  E. Arab-Tehrany,et al.  Use of Active Salmon-Lecithin Nanoliposomes to Increase Polyunsaturated Fatty Acid Bioavailability in Cortical Neurons and Mice , 2021, International journal of molecular sciences.

[6]  Rik van der Kant,et al.  Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects , 2021, Frontiers in Aging Neuroscience.

[7]  Ermias Girma Aklilu,et al.  Artificial neural network and response surface methodology for modeling and optimization of activation of lactoperoxidase system , 2021, South African Journal of Chemical Engineering.

[8]  C. N. Ravishankar,et al.  Advancements in liposome technology: Preparation techniques and applications in food, functional foods, and bioactive delivery: A review. , 2021, Comprehensive reviews in food science and food safety.

[9]  Patrick J. Lao,et al.  Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study , 2020, medRxiv.

[10]  S. Loveday,et al.  Nanoemulsion structure and food matrix determine the gastrointestinal fate and in vivo bioavailability of coenzyme Q10. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[11]  A. Fonteh,et al.  Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies , 2020, Frontiers in Physiology.

[12]  F. Wandosell,et al.  Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease , 2020, Frontiers in Synaptic Neuroscience.

[13]  K. Brouwer,et al.  Intestinal permeability and oral absorption of selected drugs are reduced in a mouse model of familial Alzheimer's disease. , 2020, Molecular pharmaceutics.

[14]  Ipek Eroglu,et al.  Liposome–ligand conjugates: a review on the current state of art , 2020, Journal of drug targeting.

[15]  M. Rosés,et al.  Lecithin liposomes and microemulsions as new chromatographic phases. , 2020, Journal of chromatography. A.

[16]  D. Watrobska-Swietlikowska.  Distribution of benzalkonium chloride into the aqueous phases of submicron dispersed systems: emulsions, aqueous lecithin dispersion and nanospheres , 2019, AAPS PharmSciTech.

[17]  J. Mudgal,et al.  Improved in vitro and in vivo hepatoprotective effects of liposomal silymarin in alcohol-induced hepatotoxicity in Wistar rats , 2019, Pharmacological reports : PR.

[18]  A. M. Rojas,et al.  High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation. , 2019, International journal of pharmaceutics.

[19]  S. Ait-Oudhia,et al.  Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer , 2018, Breast cancer.

[20]  Meng Liu,et al.  Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone. , 2017, Colloids and surfaces. B, Biointerfaces.

[21]  Ali Asram Sağıroğlu,et al.  Design, optimization and characterization of coenzyme Q10- and D-panthenyl triacetate-loaded liposomes , 2017, International journal of nanomedicine.

[22]  Mayyas Al-Remawi,et al.  Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system , 2017, Pharmaceutical development and technology.

[23]  I. Weiss,et al.  Thermal decomposition of the amino acids glycine, cysteine, aspartic acid, asparagine, glutamic acid, glutamine, arginine and histidine , 2017, bioRxiv.

[24]  M. Misran,et al.  Preparation, characterization and physicochemical properties of DOPE-PEG2000 stabilized oleic acid-soy lecithin liposomes (POLL) , 2017 .

[25]  Mohamed Mahmud,et al.  Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro , 2016, PloS one.

[26]  M. Bermejo,et al.  Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles , 2016, The AAPS Journal.

[27]  C. Sabliov,et al.  Stability and controlled release of lutein loaded in zein nanoparticles with and without lecithin and pluronic F127 surfactants , 2016 .

[28]  L. Liu,et al.  Kolliphor® HS 15 Micelles for the Delivery of Coenzyme Q10: Preparation, Characterization, and Stability , 2016, AAPS PharmSciTech.

[29]  N. Tajiri,et al.  A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus , 2016, CNS neuroscience & therapeutics.

[30]  M. Linder,et al.  Liposomal nanodelivery systems using soy and marine lecithin to encapsulate food biopreservative nisin , 2015 .

[31]  Wojasiński Michał,et al.  Lecithin-based wet chemical precipitation of hydroxyapatite nanoparticles , 2015, Colloid and Polymer Science.

[32]  N. M. Zaki.  Strategies for oral delivery and mitochondrial targeting of CoQ10 , 2014, Drug delivery.

[33]  M. Moré,et al.  Positive Effects of Soy Lecithin-Derived Phosphatidylserine plus Phosphatidic Acid on Memory, Cognition, Daily Functioning, and Mood in Elderly Patients with Alzheimer’s Disease and Dementia , 2014, Advances in Therapy.

[34]  J. Fantini,et al.  Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. , 2014, Biochemistry.

[35]  R. Shirkoohi,et al.  FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines , 2014, Journal of Cancer.

[36]  Lijuan Zhang,et al.  Preparation, characterization and cytotoxic activity of rhein argininate , 2014 .

[37]  N. Jia,et al.  Taurine attenuates amyloid β 1-42-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells. , 2014, Biochemical and biophysical research communications.

[38]  R. Saraswathi,et al.  Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery , 2014, Drug delivery.

[39]  O. Ozer,et al.  Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery , 2013, Acta pharmaceutica.

[40]  Gian Paolo Littarru,et al.  Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions. , 2013, International journal of pharmaceutics.

[41]  Rohan V. Tikekar,et al.  Effect of antioxidant properties of lecithin emulsifier on oxidative stability of encapsulated bioactive compounds. , 2013, International journal of pharmaceutics.

[42]  A. Fadda,et al.  Liposomes for brain delivery , 2013, Expert opinion on drug delivery.

[43]  G. Sandri,et al.  A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers , 2012, International journal of nanomedicine.

[44]  Gyu-Hyeok Kim,et al.  Optimisation of the processing variables for high polymer loading in compressed wood using response surface methodology , 2012 .

[45]  Mulan Jiang,et al.  Optimisation of preparation conditions and properties of phytosterol liposome-encapsulating nattokinase , 2012, Natural product research.

[46]  D. Selkoe,et al.  Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. , 2011, Archives of neurology.

[47]  Q. Fu,et al.  Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats , 2011, Journal of the Neurological Sciences.

[48]  S. Nasrollahi,et al.  Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies , 2011, International journal of nanomedicine.

[49]  D. Katz,et al.  Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. , 2010, Antiviral research.

[50]  Shaofei Xie,et al.  DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles , 2010, The AAPS Journal.

[51]  M. Jabłoński,et al.  Alzheimer's Mechanisms in Ischemic Brain Degeneration , 2009, Anatomical record.

[52]  E. Munson,et al.  Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. , 2009, Journal of pharmaceutical sciences.

[53]  A. Šmidovnik,et al.  Studies of CoQ10 and cyclodextrin complexes: solubility, thermo- and photo-stability , 2009 .

[54]  Tong Wang,et al.  Oxidative stability of egg and soy lecithin as affected by transition metal ions and pH in emulsion. , 2008, Journal of agricultural and food chemistry.

[55]  Robert Langer,et al.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.

[56]  John Woulfe,et al.  Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production , 2008, Neurobiology of Disease.

[57]  W. Lyoo,et al.  Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. , 2007, Biological & pharmaceutical bulletin.

[58]  T. Harroun,et al.  Autoinsertion of soluble oligomers of Alzheimer's Aβ(1–42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface , 2006, BMC Structural Biology.

[59]  J. Schellens,et al.  Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma , 2004, Cancer Chemotherapy and Pharmacology.

[60]  K. Edwards,et al.  Disc formation in cholesterol-free liposomes during phase transition. , 2003, Biochimica et biophysica acta.

[61]  M. Bally,et al.  Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. , 2002, Biochimica et biophysica acta.

[62]  M. Khan,et al.  Preparation and Characterization of Coenzyme Q10–Eudragit® Solid Dispersion , 2002, Drug development and industrial pharmacy.

[63]  S. Kudo,et al.  Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats. , 2001, The Journal of nutrition.

[64]  Y. Kozutsumi,et al.  Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid* , 2001, The Journal of Biological Chemistry.

[65]  R. Vile,et al.  Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  J. Jolles,et al.  Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS. , 1999, Nutrition.

[67]  G. Lou,et al.  Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease. , 1996, Journal of psychiatry & neuroscience : JPN.

[68]  T. Treves,et al.  Transdermal Physostigmine in the Treatment of Alzheimer's Disease , 1994, Alzheimer disease and associated disorders.

[69]  R. Ross,et al.  Coordinate morphological and biochemical interconversion of human neuroblastoma cells. , 1983, Journal of the National Cancer Institute.

[70]  M. Swash,et al.  PHYSOSTIGMINE IN ALZHEIMER'S DISEASE , 1979, The Lancet.

[71]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[72]  S. Giwa,et al.  FINDING THE OPTIMUM PARAMETERS FOR OIL EXTRACTION FROM SESAME SEED USING RESPONSE SURFACE METHODOLOGY , 2015 .

[73]  G. R. List,et al.  Soybean Lecithin: Food, Industrial Uses, and Other Applications , 2015 .

[74]  S. Antimisiaris,et al.  Applications of Nanoparticles for Alzheimer’s Disease Diagnosis and/or Treatment , 2015 .

[75]  J. Shin,et al.  Effect of Hydrogenated Lecithin on Cytotoxicity of Liposome , 2009 .

[76]  L. Valzelli,et al.  Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats , 2004, Psychopharmacology.

[77]  Mark W. Dewhirst,et al.  Review Hyperthermia and liposomes , 1999 .

[78]  R. Stelzmann,et al.  An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.

[79]  J. Growdon.  Use of Phosphatidylcholine in Brain Diseases: An Overview , 1987 .

[80]  R. G. Allison,et al.  Effects of consumption of choline and lecithin on neurological and cardiovascular systems. , 1982, Federation proceedings.